Sabra Healthcare REIT (NASDAQ:SBRA) Downgraded to “Sell” Rating by Wall Street Zen

Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Friday.

A number of other brokerages also recently commented on SBRA. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 target price on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Wells Fargo & Company increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Truist Financial raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Tuesday. Finally, Cantor Fitzgerald assumed coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Four equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT has a consensus rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT Stock Down 1.1%

NASDAQ SBRA opened at $18.82 on Friday. The stock has a 50 day moving average price of $19.05 and a 200-day moving average price of $18.70. Sabra Healthcare REIT has a one year low of $15.60 and a one year high of $19.97. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. The company has a market capitalization of $4.69 billion, a P/E ratio of 26.14, a P/E/G ratio of 1.32 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The company had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. During the same quarter in the previous year, the business posted $0.37 earnings per share. Sabra Healthcare REIT’s quarterly revenue was up 6.7% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several large investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC grew its stake in Sabra Healthcare REIT by 43.9% in the 4th quarter. Farther Finance Advisors LLC now owns 5,688 shares of the real estate investment trust’s stock worth $108,000 after acquiring an additional 1,736 shares in the last quarter. Assetmark Inc. grew its stake in Sabra Healthcare REIT by 15.9% in the fourth quarter. Assetmark Inc. now owns 77,377 shares of the real estate investment trust’s stock worth $1,466,000 after purchasing an additional 10,641 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Sabra Healthcare REIT by 0.5% in the fourth quarter. State of Alaska Department of Revenue now owns 154,835 shares of the real estate investment trust’s stock worth $2,930,000 after purchasing an additional 844 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in Sabra Healthcare REIT by 1,019.8% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after purchasing an additional 2,736,993 shares during the period. Finally, Diversify Advisory Services LLC raised its position in Sabra Healthcare REIT by 1.0% during the 4th quarter. Diversify Advisory Services LLC now owns 81,861 shares of the real estate investment trust’s stock valued at $1,575,000 after purchasing an additional 773 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.